Climate Change and Lung Health Training Program
Climate Change and Lung Health Training Program
批准号:
10556149
负责人:
DAVID A STOLTZ
金额:
$28.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2028-01-31
中文摘要
项目摘要/摘要
气候变化是我们时代最重要的全球问题之一。对人类健康的影响
已经感受到了,肺部发病率和死亡率越来越多地受到野火、城市和
农村空气污染,空气过敏原暴露改变,严重风暴和洪水的影响,
肺部感染的模式和严重程度的变化,以及其他因素。危害不成比例地影响
儿童、老年人、在社会经济上处于不利地位的人以及患有潜在肺部疾病的人。虽然
我们知道这一点已经有一段时间了,努力了解来自
可悲的是,气候变化和改变它们的进程是不够的。对此有多种解释
为什么我们没有取得更多的进步,但一个贡献是我们没有培养下一代
应对气候变化对肺部健康的影响。因此,我们的目标是培养学生和
气候变化对肺部的影响和战略前沿研究的博士后研究员
以减轻影响。我们拥有出色的领导力,具有互补和协同的能力;大卫博士
Stoltz博士和Peter Thorne博士分别在医学院的基础和转译肺部生物学
肺部毒理学和环境流行病学的公共卫生。我们有创意和创新
四个重点领域的导师:空气污染、过敏原、呼吸道生物学和环境挑战;
极端天气、灾害和全球变暖;以及肺部感染。除了接受博士后
伙计们,我们采取前瞻性的方式,接受博士后研究生,并提供一个暑期
为医科学生开设的课程。我们努力招聘、培训和保留种族、性别、地理(包括
农村)和社会经济多样化的受训人员群体,他们准备应对
气候变化,特别是因为这些群体是最脆弱的群体。我们现有的专业知识、计划和
兴趣使我们在这个方向上处于非常有利的地位,我们的学员将从多学科中受益
研究团队和项目,包括爱荷华州超级基金环境健康科学研究中心
研究计划,新发传染病中心,全球和区域环境中心
研究,以及关于阐明气候变化与公共健康之间的联系的合作实验室。我们的
该计划的重点是全面的研究培训,以了解和减轻气候的影响
通过多种方式改变肺部健康,包括积极的指导研究、教学课程、活动
提高写作和演示技能、社区参与度和促进职业发展的努力
发展。我们鼓励与多位科学家进行合作、建立网络和建立创造性的伙伴关系,
医疗保健提供者和社区成员推动解决方案,以解决加速
气候危机。该方案还受益于外部咨询委员会的观点和建议
由气候变化和肺部生物学的健康风险方面的世界领导者组成。
英文摘要
PROJECT SUMMARY/ABSTRACT
Climate change is one of the most important global problems of our time. The consequences for human health
are already being felt, and pulmonary morbidity and mortality are increasingly impacted by wildfires, urban and
rural air pollution, altered aero-allergen exposures, the repercussions of severe storms and flooding, the
changing patterns and severity of pulmonary infections, and other factors. The harms disproportionately affect
children, older people, the socioeconomically disadvantaged, and people with underlying lung disease. Although
we have known this for some time, efforts to understand the diverse pulmonary responses and injuries from
climate change and to alter their course have been woefully inadequate. There are multiple explanations for
why we have not made more progress, but one contributor is that we have not been training the next generation
to tackle the lung health consequences of climate change. Thus, our goal is to train students and
postdoctoral fellows for cutting edge research in the pulmonary impact of climate change and strategies
to mitigate the effects. We have outstanding leadership with complementary and synergistic skills; Dr. David
Stoltz in the College of Medicine in basic and translational lung biology, and Dr. Peter Thorne in the College of
Public Health in pulmonary toxicology and environmental epidemiology. We have creative and innovative
mentors in four areas of emphasis: air pollution; allergens, airway biology, and environmental challenges;
extreme weather, disasters, and global warming; and lung infections. In addition to accepting post-doctoral
fellows, we take a forward-looking approach by accepting predoctoral graduate students and offering a summer
program for medical students. We strive to recruit, train, and retain a racially, gender, geographically (including
rural), and socioeconomically diverse group of trainees who are prepared to tackle the health consequences of
climate change, especially because those are the groups most vulnerable. Our existing expertise, programs and
interests position us exceedingly well for this direction, and our trainees will benefit from multidisciplinary
research teams and programs including the Environmental Health Sciences Research Center, Iowa Superfund
Research Program, Center for Emerging Infectious Diseases, Center for Global & Regional Environmental
Research, and a Collaboratory on Illuminating the Nexus Between Climate Change and Public Health. Our
program is focused on comprehensive training in research to understand and mitigate the impact of climate
change on lung health via multiple modalities that include active mentored research, didactic courses, activities
that enhance writing and presentation skills, community engagement, and endeavors that facilitate career
development. We encourage collaboration, networking, and creative partnerships with multiple scientists,
healthcare providers, and community members to advance solutions to the pulmonary harms of the accelerating
climate crisis. The program also benefits from the perspective and advice of an External Advisory Committee
composed of world leaders in the health risks of climate change and lung biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health
-
批准号:10597111
-
项目类别:
-
资助金额:$62.95万
-
财政年份:2022
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10677590
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10024664
-
项目类别:
-
资助金额:$61.06万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10248526
-
项目类别:
-
资助金额:$60.83万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10470334
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
-
批准号:10155587
-
项目类别:
-
资助金额:$105.36万
-
财政年份:2017
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
-
批准号:9289053
-
项目类别:
-
资助金额:$107.03万
-
财政年份:2017
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
-
批准号:9918957
-
项目类别:
-
资助金额:$105.46万
-
财政年份:2017
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Goblet Cells: Friend or Foe?
-
批准号:8355114
-
项目类别:
-
资助金额:$226.5万
-
财政年份:2012
-
负责人:DAVID A STOLTZ
-
依托单位:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
-
批准号:8110743
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2010
-
负责人:DAVID A STOLTZ
-
依托单位:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
-
批准号:7919812
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:DAVID A STOLTZ
-
依托单位:
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease
-
批准号:10470210
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Core A: Animals Models-Stoltz
-
批准号:10470206
-
项目类别:
-
资助金额:$71.22万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Origins of Cystic Fibrosis Airway Disease
-
批准号:10470203
-
项目类别:
-
资助金额:$229.33万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Porcine PPG Administration Core
-
批准号:10470205
-
项目类别:
-
资助金额:$6.23万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Origins of Cystic Fibrosis Airway Disease
-
批准号:10226930
-
项目类别:
-
资助金额:$229.38万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Core A: Animals Models-Stoltz
-
批准号:10226932
-
项目类别:
-
资助金额:$71.27万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Porcine PPG Administration Core
-
批准号:10226931
-
项目类别:
-
资助金额:$6.23万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease
-
批准号:10226937
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
-
批准号:7994211
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2007
-
负责人:DAVID A STOLTZ
-
依托单位:
海外基金